ProMIS Neurosciences Inc.
Last updated September 27, 2026
Organization details
- Legal name
- ProMIS Neurosciences Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- Canada
- Ticker symbol
- PMN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001374339
Board of directors
-
Eugene Williams · DirectorSince 2024
-
Gail M. Farfel · Director · Chief Executive OfficerSince 2023
-
Gavin T. Malenfant · Director · Chief Operating OfficerSince 2023
-
Josh Mandel-Brehm · DirectorSince 2024
-
Madge K. Shafmaster · DirectorSince 2024
-
Neil Cashman · Director · Chief Scientific OfficerSince 2023
-
Neil K. Warma · Director · Chief Executive OfficerSince 2025
-
Patrick D. Kirwin · DirectorSince 2023
-
Slanix Paul Alex · DirectorSince 2025
-
William W. Wyman · DirectorSince 2024
Chief executives
Gail M. Farfel
· Chief Executive Officer
Dates unknown
Neil K. Warma
· Chief Executive Officer
Dates unknown
Board connections
2 of this board's directors also sit on 2 other boards.
- via Josh Mandel-Brehm
- via Gail M. Farfel
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $8,756,750
- 9 purchases by 5 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 5, 2026 | Kaplan Johanne Officer (Chief Development Officer) | Open-market purchase | +2,280 | $13.30 | $30,324 |
| Apr 22, 2026 | Patrick D. Kirwin Director | Open-market purchase | +4,000 | $11.33 | $45,320 |
| Mar 5, 2026 | Eugene Williams Director | Open-market purchase | +2,000 | $24.40 | $48,800 |
| Mar 4, 2026 | Eugene Williams Director | Open-market purchase | +2,000 | $24.00 | $48,000 |
| Mar 3, 2026 | Eugene Williams Director | Open-market purchase | +1,000 | $21.89 | $21,890 |
| Mar 2, 2026 | Eugene Williams Director | Open-market purchase | +1,000 | $22.53 | $22,530 |
| Feb 19, 2026 | Kaplan Johanne Officer (Chief Development Officer) | Open-market purchase | +1,629 | $15.35 | $25,005 |
| Feb 3, 2026 | Neil Cashman Director, Officer (Chief Scientific Officer) | Grant or award | +4,122 | $12.13 | $50,000 |
| Feb 3, 2026 | Kaplan Johanne Officer (Chief Development Officer) | Grant or award | +2,060 | $12.13 | $24,988 |
| Feb 3, 2026 | Neil K. Warma Director, Officer (Chief Executive Officer) | Grant or award | +6,183 | $12.13 | $75,000 |
| Feb 3, 2026 | Milbury Max A. Principal Accounting Officer | Grant or award | +6,595 | $12.13 | $79,997 |
| Feb 3, 2026 | Patrick D. Kirwin Director | Grant or award | +3,050 | $12.13 | $36,997 |
| Feb 3, 2026 | Slanix Paul Alex Director | Open-market purchase | +700,741 | $12.13 | $8,499,988 |
| Oct 3, 2025 | Milbury Max A. Principal Accounting Officer | Open-market purchase | +30,392 | $0.49 | $14,892 |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust 10% owner | In-the-money exercise | +697,674 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.